Pharmaceutical company Mylan Inc. (Nasdaq: MYL) is buying part of Famy Care Ltd. for $750 million.

Famy, headquartered in Mumbai, India, is a women's health care company that specializes in birth control, including injectable contraceptives, intra-uterine devices, tubal rings and hormone replacement therapy products.  To execute the deal, Famy is pinning off its female health care business under a court-approved scheme of demerger – then Mylan will acquire all of the shares of the new resulting company.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.